Re-Evaluating Natriuretic Peptides as Biomarkers of Cardiac Allograft Vasculopathy

Purpose: Despite initial evidence supporting the use of elevated B-type natriuretic peptide (BNP) to predict cardiac allograft vasculopathy (CAV), a recent meta-analysis questioned the diagnostic accuracy of BNP and N-terminal-pro brain natriuretic peptide (NT-proBNP) in the detection of CAV following heart transplantation (HTx). To our knowledge, no study has assessed both BNP and NT-proBNP in the prediction of CAV in HTx.

Source: The Journal of Heart and Lung Transplantation - April 1, 2024 Category: Transplant Surgery Authors: , A. Yadalam, M.E. Gold, P. Patel, J. Waller, A.S. Gillet, A. Panagopoulos, A. Alkhoder, Z. Siddiqui, O. Khawaja, H. Allaqaband, S. Sakr, A. Rahbar, Y. Haroun, H. Hashmi, A. Shamim, K. Ejaz, D. Gupta, W. Book, A.A. Quyyumi Source Type: research